{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:21:25Z","timestamp":1762262485589,"version":"build-2065373602"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"DOI":"10.7759\/cureus.96070","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:11:52Z","timestamp":1762261912000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Airway Swelling in a Patient With Lymphoproliferative Disorder: A Diagnostic Challenge Between Anaphylaxis and Acquired Angioedema"],"prefix":"10.7759","author":[{"given":"Mahmudul Hasan","family":"Nahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-6-14","article-title":"Acquired angioedema","volume":"6","author":"Cicardi M","year":"2010","unstructured":"Cicardi M, Zanichelli A. Acquired angioedema. Allergy Asthma Clin Immunol. 2010, 6:14. 10.1186\/1710-1492-6-14","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork K","year":"2000","unstructured":"Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 2000, 356:213-7. 10.1016\/s0140-6736(00)02483-1","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-018-0229-4","article-title":"Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey","volume":"8","author":"Zanichelli A","year":"2018","unstructured":"Zanichelli A, Magerl M, Longhurst HJ, et al.. Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey. Clin Transl Allergy. 2018, 8:42. 10.1186\/s13601-018-0229-4","journal-title":"Clin Transl Allergy"},{"key":"ref4","unstructured":"Resuscitation Council UK. emergency treatment of anaphylaxis guidelines for healthcare providers. (2021). https:\/\/www.resus.org.uk\/sites\/default\/files\/2021-05\/Emergency%20Treatment%20of%20Anaphylaxis%20May%202021_0.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona V","year":"2020","unstructured":"Cardona V, Ansotegui IJ, Ebisawa M, et al.. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J. 2020, 13:100472. 10.1016\/j.waojou.2020.100472","journal-title":"World Allergy Organ J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000339749","article-title":"Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients","volume":"160","author":"Sala-Cunill A","year":"2013","unstructured":"Sala-Cunill A, Cardona V, Labrador-Horrillo M, et al.. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013, 160:192-9. 10.1159\/000339749","journal-title":"Int Arch Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi M","year":"2014","unstructured":"Cicardi M, Aberer W, Banerji A, et al.. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014, 69:602-16. 10.1111\/all.12380","journal-title":"Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update","volume":"77","author":"Maurer M","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, et al.. The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update. Allergy. 2022, 77:1961-90. 10.1111\/all.15214","journal-title":"Allergy"},{"key":"ref9","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"13","author":"Castelli R","year":"2013","unstructured":"Castelli R, Zanichelli A, Cicardi M, Cugno M. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Crit rev oncol\/hematol. 2013, 13:323-32.","journal-title":"Crit rev oncol\/hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s1567-5769(02)00162-5","article-title":"Bradykinin and the pathophysiology of angioedema","volume":"3","author":"Cugno M","year":"2003","unstructured":"Cugno M, Nussberger J, Cicardi M, Agostoni A. Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol. 2003, 3:311-7. 10.1016\/s1567-5769(02)00162-5","journal-title":"Int Immunopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9542656","article-title":"Anaphylactic degranulation of mast cells: focus on compound exocytosis","volume":"2019","author":"Klein O","year":"2019","unstructured":"Klein O, Sagi-Eisenberg R. Anaphylactic degranulation of mast cells: focus on compound exocytosis. J Immunol Res. 2019, 2019:9542656. 10.1155\/2019\/9542656","journal-title":"J Immunol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner PJ","year":"2015","unstructured":"Turner PJ, Gowland MH, Sharma V, et al.. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2015, 135:956-63.e1. 10.1016\/j.jaci.2014.10.021","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01733.x","article-title":"Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization","volume":"63","author":"Kemp SF","year":"2008","unstructured":"Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008, 63:1061-70. 10.1111\/j.1398-9995.2008.01733.x","journal-title":"Allergy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi M","year":"2010","unstructured":"Cicardi M, Banerji A, Bracho F, et al.. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010, 363:532-41. 10.1056\/NEJMoa0906393","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/all.12303","article-title":"Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema","volume":"69","author":"Aberer W","year":"2014","unstructured":"Aberer W, Maurer M, Reshef A, et al.. Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema. Allergy. 2014, 69:305-14. 10.1111\/all.12303","journal-title":"Allergy"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2014.12.007","article-title":"Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department","volume":"114","author":"Bernstein JA","year":"2015","unstructured":"Bernstein JA, Moellman JJ, Collins SP, Hart KW, Lindsell CJ. Effectiveness of ecallantide in treating angiotensin-converting enzyme inhibitor-induced angioedema in the emergency department. Ann Allergy Asthma Immunol. 2015, 114:245-9. 10.1016\/j.anai.2014.12.007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.16773","article-title":"Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial","volume":"320","author":"Banerji A","year":"2018","unstructured":"Banerji A, Riedl MA, Bernstein JA, et al.. Effect of lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial. J Am Med Assoc. 2018, 320:2108-21.","journal-title":"J Am Med Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428720-recurrent-airway-swelling-in-a-patient-with-lymphoproliferative-disorder-a-diagnostic-challenge-between-anaphylaxis-and-acquired-angioedema","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:12:05Z","timestamp":1762261925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428720-recurrent-airway-swelling-in-a-patient-with-lymphoproliferative-disorder-a-diagnostic-challenge-between-anaphylaxis-and-acquired-angioedema"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.96070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}